A 13-year-old girl who relapsed with a particular type of blood cancer is now leukaemia-free after a world-first use of what scientists have described as the most sophisticated cell engineering to date.independent.co.uk/news/scie...
Teenager Leukaemia free after a world-first us... - CLL Support
Teenager Leukaemia free after a world-first use of sophisticated cell engineering.
Written by
Juliette02
To view profiles and participate in discussions please or .
The ability to reply to this post has been turned off.
1 Reply
•
AussieNeilPartnerAdministrator
This is a VERY popular news item. Here's the previous discussion: healthunlocked.com/cllsuppo...
I've turned off replying to your post, so that we can have all the discussion in one post, but thank you for an excellent title and introduction to the news item from another source to the BBC article.
Neil
Not what you're looking for?
You may also like...
Interesting recently published overview of Chronic Lymphocytic Leukaemia and Hairy-Cell Leukaemia
From the cancer network, home of the Oncology Journal
Recently published six page overview of...
GVHD after a stem cell transplant
I had a stem cell transplant from a non-related donor almost four months ago and got graft versus...
Blood transfusion after first round of FCR
Am I just unlucky? The start of the FCR went so well, though I was breathless from the first dose...
Israeli Scientists have developed an oral Covid-19 vaccine
"While working on the avian [coronovirus] vaccine, the scientists said they identified a possible...
Hospital response to lack of monitoring after first FCR
Just had a call back from a (lady) doctor after my call to the (male) consultant and (male) trial...
Related Posts
Early use of Ibrutinib or is W&W still a needed strategy?
Is fatigue always a side effect of long term use of Ibrutinib?
Richter transformation of chronic lymphocytic leukaemia: a British Society for Haematology Good Practice Paper
Episode 115: Cutting Edge Therapy: Cancer Cured After Years of Battling CLL | Brian Koffman
Remission with Ibrutinib and Venetoclax
